Skip to content

BioLife Solutions BLFS Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
EBITDA margin-14.8%+1.1pp-15.9%0.0pp-15.9%
Returns
Return on invested capital-4.9%+0.5pp-5.4%-0.3pp-5%
Efficiency
Asset turnover0.3×0.0×0.2×0.0×0.2×
Liquidity
Current ratio7.3×+1.4×5.9×+1.3×4.7×+0.2×4.4×-0.3×4.7×+0.2×
Quick ratio5.5×+0.9×4.6×+1.0×3.6×+0.2×3.5×-0.3×3.7×+0.1×
Cash ratio1.3×-0.2×1.4×+0.4×1.1×0.0×1.1×-1.3×2.4×-0.5×
Leverage
Debt-to-equity0.0×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Debt-to-assets0.0×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Interest coverage-5.4×+0.9×-6.4×
Per Share
Book value per share$7.56-1.1%$7.64+5.3%$7.260.0%$7.26-0.4%$7.29-3.7%
Valuation
Market capitalization$1.34B+33.1%$1.16B-4.7%$1.22B+17.9%$1.04B-3.2%$1.07B-11.0%
Enterprise value$1.34B+38.1%$1.15B-5.3%$1.21B+17.9%$1.03B-0.3%$1.03B-9.5%
Price / sales13.5×+0.6×12.3×-1.1×13.5×
Price / book3.6×+0.7×3.1×-0.3×3.5×+0.5×-0.1×-0.4×
EV / sales13.4×+1.0×12.2×-1.2×13.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are BioLife Solutions's profit margins?
BioLife Solutions (BLFS) runs a 66.9% gross margin and a -16.7% operating margin, with a -68.7% net margin.
Where do BioLife Solutions's ratios come from?
Every ratio is computed from BioLife Solutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.